Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A, Severe”

277 trials

Showing 20 of 277 results

Large-scale testing (Phase 3)Study completedNCT01992549
What this trial is testing

Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII

Who this might be right for
Severe Hemophilia A
Octapharma 48
Not applicableUnknownNCT00324493
What this trial is testing

Musculoskeletal Function in Hemophilia

Who this might be right for
Hemophilia
Christian Medical College, Vellore, India 250
Large-scale testing (Phase 3)Looking for participantsNCT06142552
What this trial is testing

Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein

Who this might be right for
Severe Hemophilia A
Jiangsu Gensciences lnc. 120
Early research (Phase 1)Study completedNCT01184820
What this trial is testing

Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose Administration

Who this might be right for
Hemophilia A
Bayer 14
Large-scale testing (Phase 3)Study completedNCT02250560
What this trial is testing

Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.

Who this might be right for
Haemophilia B
Bio Products Laboratory
Not applicableLooking for participantsNCT05981274
What this trial is testing

A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)

Who this might be right for
Severe Hemophilia A Without Inhibitor
Tri-Service General Hospital 45
Testing effectiveness (Phase 2)Study completedNCT03370172
What this trial is testing

BAX 888 in Male Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Large-scale testing (Phase 3)Study completedNCT05707351
What this trial is testing

Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
Takeda 37
Not applicableStudy completedNCT02634723
What this trial is testing

Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 21
Large-scale testing (Phase 3)Study completedNCT01507896
What this trial is testing

BAX 326 Surgery Study in Hemophilia B Patients

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Early research (Phase 1)Study completedNCT02920398
What this trial is testing

A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 21
Large-scale testing (Phase 3)Study completedNCT02954575
What this trial is testing

Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Octapharma 57
Early research (Phase 1)Study completedNCT00716716
What this trial is testing

Phase I/IIa Study of FIXFc in Hemophilia B Patients

Who this might be right for
Hemophilia B
Bioverativ Therapeutics Inc. 10
Large-scale testing (Phase 3)WithdrawnNCT02196207
What this trial is testing

Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform

Who this might be right for
Severe Hemophilia A
Margaret Ragni
Early research (Phase 1)Study completedNCT02571569
What this trial is testing

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 32
Post-approval studies (Phase 4)UnknownNCT04534751
What this trial is testing

Factor In the Initial Resuscitation of Severe Trauma 2 Patients

Who this might be right for
Traumatic HemorrhageCoagulopathyMassive Hemorrhage
University Health Network, Toronto 350
Large-scale testing (Phase 3)Study completedNCT01736475
What this trial is testing

Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)

Who this might be right for
Hemophilia A
Baxalta now part of Shire 159
Early research (Phase 1)Study completedNCT03481946
What this trial is testing

Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe Hemophilia

Who this might be right for
Hemophilia A; Hemophilia B
Bayer 6
Not applicableStudy completedNCT05752565
What this trial is testing

Physical Activity and FVIII Elimination: Relevance to Personalized Therapy in Severe Hemophilia A

Who this might be right for
Hemophilia A
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Testing effectiveness (Phase 2)Looking for participantsNCT06379789
What this trial is testing

Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Who this might be right for
Hemophilia B
Regeneron Pharmaceuticals 130
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation